Risk Factors |
Is frailty is an independent risk factor for delirium? |
Determine the role/impact/effect of cognitive functioning in frailty. |
How does comorbidity, both medical and neurological, interact with frailty and delirium? |
Pathophysiology |
What are the common pathophysiological mechanisms of frailty and delirium? |
Are there genetic predispositions? |
Do frailty and delirium share biomarkers (e.g. cytokines)? |
Recovery from Stressor |
Does delayed or incomplete recovery from a stressor signify pre-stressor frailty? |
Does delirium trigger a transition from a pre-frail state to frailty? |
Can delirium be used as a model for a stressor to examine the subsequent frailty course? |
Long-term Outcomes |
Is there anything unique about delirium as a “precipitant” of frailty that would modify the known relationship between frailty and adverse functional outcomes? |
Does delirium cause long-term cognitive and functional decline? |
Does recovery from frailty describe a resilience that protects against negative long-term outcomes? |
Prevention |
Does preventing delirium prevent subsequent frailty? |
Does prevention or treatment of frailty reduce delirium risk? |
Treatments |
Are there common prevention or treatment interventions that can be used for frailty and delirium? |
Will multidisciplinary programs impact on the course of frailty or delirium? |
System |
Are there systemic measures that can capture delirium and frailty in existing records to define the scope of the problem? |
Will incentives to prevent delirium have an impact on subsequent frailty? |
What are the cost implications of superimposed delirium and frailty to the patient, institution, physician, system, and society? |